发明名称 Self emulsifying lipid matrix (SELM).
摘要 A pharmaceutical composition for oral administration of an active compound having a bioavailability of 20% or less. The composition comprises, based on its total weight, from 0.01% to about 15% (w/w) of said active compound molecularly dissolved in the composition, from 30 to 80% (w/w) of an edible lipid matrix and from 1 to 20% (w/w) of an edible emulsifier, the ratio between the dose weight of the active compound and its solubility in the composition being equal to or greater than 0.6 ml. The high percentage of fat (30-80%) enables a considerable increase the amount of the drug that is molecularly dispersed in the dosage form, thus allowing a significant reduction in the number of unit doses that must be taken daily-by patients.
申请公布号 ZA200304263(B) 申请公布日期 2004.03.26
申请号 ZA20030004263 申请日期 2003.05.30
申请人 F. HOFFMANN-LA ROCHE AG. 发明人 MARTIN KUENTZ;DIETER ROETHLISBERGER
分类号 A61K47/14;A61K9/14;A61K31/4409;A61K31/496;A61K31/5377;A61K45/00;A61K47/24;A61K47/44;A61P25/00;A61P29/00 主分类号 A61K47/14
代理机构 代理人
主权项
地址